Market Overview and Dynamics

The North America anatomic pathology market is projected to grow from US$ 8,870.41 million in 2021 to US$ 13,970.95 million by 2028, expanding at a CAGR of 6.7% during the forecast period. This growth is primarily driven by the rising prevalence of cancer and chronic diseases, along with the increasing focus on personalized medicine. However, market expansion is challenged by a shortage of skilled professionals and the stringent regulatory landscape.

📚Download Full PDF Sample Copy of Market Report @
https://www.businessmarketinsights.com/sample/TIPRE00026306

Cancer continues to exert a profound impact on global health systems, being one of the leading causes of death. As per the National Cancer Institute, 2018 saw 18.1 million new cases and 9.5 million cancer-related deaths worldwide. Notably, cancer accounts for nearly 30% of premature deaths from noncommunicable diseases among adults aged 30–69, with lung cancer being the most frequently diagnosed type globally.

The increasing prevalence of other diseases, such as diabetes, particularly in middle-income nations, also contributes to the market’s growth. According to the IDF Diabetes Atlas (2019), around 463 million adults aged 20–79 were living with diabetes globally, a number expected to rise to 700 million. Key contributors to this trend include rising obesity rates, unhealthy diets, and sedentary lifestyles.

As the incidence of cancer and other targeted diseases rises, government bodies, healthcare providers, and research institutions are intensifying their efforts toward early diagnosis and advanced treatment methods. This growing burden is propelling demand in the anatomic pathology space.

Additionally, the increasing adoption of personalized medicine, especially for conditions like breast cancer and cardiovascular diseases, is a significant growth catalyst. Personalized treatments typically offer fewer side effects and are tailored to individual patient profiles, enhancing treatment outcomes. With ongoing research and clinical advancements, personalized medicine is expected to play an even more prominent role in the future, further driving demand for anatomic pathology solutions.

Impact of COVID-19

The COVID-19 pandemic has had a disruptive impact on the diagnostics industry, including the anatomic pathology sector. Clinic and OR closures, along with “stay-at-home” mandates across North America, significantly reduced specimen collection and evaluation activities.

During the pandemic, many scheduled surgeries were postponed, and routine diagnostic visits declined. Early cancer detection programs were deactivated, and autopsy services were halted. According to the World Economic Forum, approximately 28 million elective surgeries and 38% of global cancer surgeries were delayed, leading to a substantial drop in pathology lab sample volumes.

These disruptions negatively affected diagnostic test volumes and anatomic pathology product sales, especially in Q2 2020. Moreover, pathology labs redirected their focus and resources toward COVID-19 testing, deprioritizing other diagnostic services.

As lockdown measures have eased, hospitals are gradually resuming elective procedures, leading to a rebound in diagnostic testing. However, the pandemic’s overall effect has slightly dampened the growth trajectory of the anatomic pathology market compared to pre-pandemic projections.

Key Market Segments

• By Product & Service:
  • Services held the largest market share in 2021.
  • Instruments are expected to register the highest CAGR during the forecast period.
• By Application:
  • Disease Diagnosis dominated the market in 2021.
  • Drug Discovery & Development is projected to witness the highest growth rate between 2021 and 2028.
• By End User:
  • Hospitals accounted for the largest market share in 2021.
  • Diagnostic Laboratories are anticipated to grow at the highest CAGR in the coming years.
  • The “Others” segment includes pharmaceutical & biotechnology companies and contract research organizations (CROs).

Major Data Sources and Organizations Referenced

• Centers for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• College of American Pathologists (CAP)

Reasons to Purchase This Report

• Identify high-potential investment areas through detailed trend analysis of the North America anatomic pathology market.
• Gain comprehensive insights into market drivers, segment dynamics, and technological advancements.
• Understand country-specific opportunities and align resources with regional growth strategies.
• Explore key distribution channels and future pathways for revenue expansion.
• Leverage knowledge on government initiatives and research programs to shape competitive positioning in the market.

Market Introduction

The anatomic pathology is a significant part of the study and treatment of the diseases. Anatomic pathology is a broad field that includes decedent pathology, surgical pathology, cytopathology, neuropathology, and ophthalmic pathology. The anatomic pathology is usually performed in the medical laboratories of hospitals and diagnostics laboratories.

North America Anatomic Pathology Strategic Insights

Strategic insights for the North America Anatomic Pathology provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

 key company profiles

  F. HOFFMANN-LA ROCHE LTD.

  Danaher

  Hologic, Inc.

  Agilent Technologies, Inc.

  BioGenex

  Diapath S.p.A.

  Bio SB

  MERCK KGaA

  BD

  PHC Holdings Corporation

North America Anatomic Pathology Regional Insights

The geographic scope of the North America Anatomic Pathology refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Défense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications

Author’s Bio
Akshay
Senior Market Research Expert at Business Market Insights